Itron (ITRI) Reports Q1 Earnings: What Key Metrics Have to Say

Zacks Zacks Öffnen unter Zacks
Itron (ITRI) Reports Q1 Earnings: What Key Metrics Have to Say

For the quarter ended March 2026, Itron (ITRI) reported revenue of $586.98 million, down 3.3% over the same period last year. EPS came in at $1.49, compared to $1.52 in the year-ago quarter.

The reported revenue represents a surprise of +2.81% over the Zacks Consensus Estimate of $570.97 million. With the consensus EPS estimate being $1.26, the EPS surprise was +18.73%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Itron performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue- Outcomes: $95.91 million compared to the $92.09 million average estimate based on four analysts. The reported number represents a change of +22.1% year over year. Revenue- Device Solutions: $124.38 million versus the four-analyst average estimate of $115.06 million. The reported number represents a year-over-year change of -1.2%. Revenue- Networked Solutions: $350.66 million versus $352.57 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -12.9% change. Revenue- Product revenues- Device Solutions: $123.73 million versus $116.07 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -1.3% change. Revenue- Service revenues- Networked Solutions: $29.52 million compared to the $28.8 million average estimate based on three analysts. The reported number represents a change of +4.6% year over year. Revenue- Product revenues- Networked Solutions: $321.15 million versus $321.83 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -14.3% change. Revenue- Product revenues: $477.8 million versus $470.8 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -8.7% change. Revenue- Service revenues: $109.18 million compared to the $107.36 million average estimate based on two analysts. The reported number represents a change of +30% year over year. Revenue- Service revenues- Outcomes: $64.04 million versus the two-analyst average estimate of $65.64 million. The reported number represents a year-over-year change of +15.8%. Revenue- Service revenues- Device Solutions: $0.65 million compared to the $0.46 million average estimate based on two analysts. The reported number represents a change of +34.1% year over year. Revenue- Resiliency Solutions: $16.03 million versus the two-analyst average estimate of $13.5 million. Revenue- Product revenues- Outcomes: $31.87 million versus the two-analyst average estimate of $26.59 million. The reported number represents a year-over-year change of +37.2%.

View all Key Company Metrics for Itron here>>>

Shares of Itron have returned +3.6% over the past month versus the Zacks S&P 500 composite's +12.8% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Itron, Inc. (ITRI): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research